UREMIC TOXINS / MICROBIOME

Size: px
Start display at page:

Download "UREMIC TOXINS / MICROBIOME"

Transcription

1 UREMIC TOXINS / MICROBIOME R Vanholder University Hospital, Gent, Belgium

2 COMPLEX PATHO-PHYSIOLOGY Ikizler et al, KI, 84: ;

3 UREMIC TOXINS NUTRITION 3 3

4 THE IMPACT OF NUTRITION ON THE UREMIC SYNDROME

5 UREMIC TOXINS NUTRITION 5 5

6 ROLE INTESTINE IN GENERATION CRESOLS p-cresol thyrosine intestinal flora intestinal wall liver p-cresylsulfate p-cresylglucuronide Schepers et al, Blood Purif, 29: ;

7 Vanholder et al, JASN, 25: ;

8 FLOW CHART REVIEW PROCEDURES Figure 1. Flowchart of the review procedure and quality scoring. Vanholder et al, JASN, 25: ;

9 INDOXYLSULFATE AND P-CRESYLSULFATE HAVE BEEN LINKED TO A MYRIAD OF TOXIC EFFECTS: Leukocyte activation Endothelial morphological and functional changes Endothelial/leukocyte interaction Smooth muscle cell proliferation Whole vessel calcification & senescence Cardiac fibrosis and myohypertrophy Skeletal resistance to PTH Insulin resistance Renal tubular damage 9 9

10 COMMON PATHWAYS IN ENDOTHELIUM Vanholder et al, JASN, 25: ;

11 TMAO ENHANCES ATHEROGENESIS Wang et al, Nature, 472: 57-63;

12 TMAO ENHANCES ATHEROGENESIS Metabolomic analysis unraveled TMAO as linked to vascular disease Sources of TMAO: Choline, fosfatidyl choline, betaine Red meat, shellfish, eggs, dairy products Wang et al, Nature, 472: 57-63;

13 TMAO ENHANCES ATHEROGENESIS Role of intestinal microbiota: effect precursors TMAO neutralized by antibiotics Wang et al, Nature, 472: 57-63;

14 TMAO CLEARANCE BY DIALYSIS IS IN THE RANGE OF OTHER SMALL WATER SOLUBLE COMPOUNDS Hai et al, Plos One, e ,;

15 TMAO CLEARANCE BY DIALYSIS IS IN THE RANGE OF OTHER SMALL WATER SOLUBLE COMPOUNDS Urea Creatinine TMAO Normals* 55 ± ± ±78 ESRD** 258 ± ± ±72 *: renal clearance; **: dialyzer clearance Hai et al, Plos One, e ,;

16 INDOXYL SULFATE + P-CRESYL SULFATE: OUTCOME Clin J Am Soc Nephrol 4: ;

17 INDOXYL SULFATE AND SURVIVAL Kaplan-Meyer estimates of overall mortality for patients as a function of tertiles for serum IS levels Number of patients at risk Barreto et al, CJASN, 4: ;

18 PROOF OF CONCEPT

19 PLASMA PROTEIN BOUND SOLUTES ARE DECREASED IN GERMFREE MICE Wikoff et al, PNAS, 106: ;

20 PLASMA PROTEIN BOUND SOLUTES ARE DECREASED IN GERMFREE MICE Fig. 3. Sulfate profiling based on constant neutral loss scanning of 80 m/z in ESI mode for conv (Upper) and GF (Lower) pooled plasma samples. The m/z values for several species are listed above their respective peak. Identified sulfates include: phenyl sulfate (a), indoxyl sulfate (b), p-cresol sulfate (c), equol sulfate (d), and methyl equol sulfate (e). Wikoff et al, PNAS, 106: ;

21 THE COLON CONTRIBUTES TO UREMIC TOXIN GENERATION Aronov et al, JASN, 22: ;

22 THE COLON CONTRIBUTES TO UREMIC TOXIN GENERATION Aronov et al, JASN, 22: ;

23 THE COLON CONTRIBUTES TO UREMIC TOXIN GENERATION Aronov et al, JASN, 22: ;

24 THE COLON CONTRIBUTES TO UREMIC TOXIN GENERATION Aronov et al, JASN, 22: ;

25 BUT THERE IS MORE THAN THAT

26 INTESTINAL MICROBIOTA ARE MODIFIED IN CKD Vaziri et al, KI, 83: ;

27 Fig. 4 - Hierarchical clustering of probe sets representing significantly different operational taxonomic units (OTUs) between groups with a minimum two-fold change in untransformed intensities between samples to show relative abundance. Yellow indicates increased abundance and red indicates decreased abundance relative to the mean for each OTU. Columns represent rat fecal microbiota composition for control (CTL) and chronic renal failure (CRF) individual rats. Rows are OTUs with mean fold change among samples and cluster based on the similarity of their abundance profiles across the data set, with similar OTUs connected at the hierarchical tree on the left. Bars on the right represent (1) OTUs from the Firmicutes (especially Lactobacillaceae and a few Coprococcus within the Lachnospiraceae), Bacteroidetes (Prevotellaceae, two Rikenellaceae OTUs) that had higher abundances in CTL samples, or (2) OTUs from the Firmicutes (unclassified Lachnospiraceae) and other Rikenellaceae (in Bacteroides) that have higher abundances in CRF samples. Vaziri et al, KI, 83: ;

28 CHANGES IN ASSIMILATION MODIFY THE GENERATION OF P-CRESYLSUFATE Bammens et al, KI, 64: ;

29 CHANGES IN ASSIMILATION MODIFY THE GENERATION OF P-CRESYLSUFATE Group A: GFR > 60 Group B: GFR Group C: GFR < 30 (A) The median values of urinary p-cresol output (mg/24 hours) in the three study groups. (B) The median values of the urinary p-cresol (mg/24 hours)/urinary urea nitrogen (g/24 hours) ratio. *P < 0.05 vs. group A. Bammens et al, KI, 64: ;

30 CKD DISTURBS INTEGRITY OF THE INTESTINAL EPITHELIUM Vaziri et al, NDT, 27: ;

31 CKD DISTURBS INTEGRITY OF THE INTESTINAL EPITHELIUM Vaziri et al, NDT, 27: ;

32 CKD IS ASSOCIATED WITH TRANSLOCATION OF GUT BACTERIAL DNA GUT GENUS DETECTED IN BLOOD (% OF TOTAL GUT GENUS) Wang et al, Nephrology, 17: ;

33 CKD IS ASSOCIATED WITH TRANSLOCATION OF GUT BACTERIAL DNA GUT GENUS DETECTED IN BLOOD (% OF TOTAL GUT GENUS) Wang et al, Nephrology, 17: ;

34 CKD IS ASSOCIATED WITH TRANSLOCATION OF GUT BACTERIAL DNA GUT GENUS DETECTED IN BLOOD (% OF TOTAL GUT GENUS) Controls (n=10) ESRD (n=30) Klebsiella spp Proteus spp Escherichia spp Enterobacter spp Pseudomonas spp P Wang et al, Nephrology, 17: ;

35 THERAPEUTIC OPTIONS Diet Cave malnutrition Prebiotics Non-digestible compounds beneficially modifying composition and/or function of intestinal flora Probiotics Bacteria adminstered as food components or supplements providing specific benefits themselves Synbiotics Prebiotics + probiotics Sorbents Schepers et al, Blood Purif, 29: ;

36 Vanholder and Glorieux, Clin Kidney J, 8: ;

37 Unfortunately, the quality and the evidence base of many of these studies are debatable, especially in uraemia, and often results within one study or among studies are contradictory. Vanholder and Glorieux, Clin Kidney J, 8: ;

38 URINARY PROTEIN BOUND TOXINS ARE LOWER IN VEGETARIANS Patel et al, cjasn, 7: ;

39 URINARY PROTEIN BOUND TOXINS ARE LOWER IN VEGETARIANS Table 2. Urinary excretion of PCS and IS Vegetarian Unrestricted P Value (Vegetarian versus Unrestricted) Period 1 Period 2 Period 1 Period 2 Period 1 Period 2 PCS (mg/d per 1.73 m2) 30 (11 74) 23 (17 47) 100 (47 124) 95 (20 124) IS (mg/d per 1.73 m2) 24 (12 42) 19 ( 17 26) 47 (40 59) 52 (39 58) <0.001 Patel et al, cjasn, 7: ;

40 P-CRESYLSULFATE INDUCES INSULIN RESISTANCE Koppe et al, JASN, 24: 88-99;

41 PREBIOTIC AXOS REDUCES P-CRESYLSULFATE AND CORRECTS UREMIC INSULIN RESISTANCE IN MICE Koppe et al, JASN, 24: 88-99;

42 DECREASE UREMIC TOXINS WITH SYNBIOTICS: RCT Rossi et al, cjasn, 11: ;

43 DECREASE UREMIC TOXINS WITH SYNBIOTICS: RCT IS - AB FREE (N=21) IS -TOTAL (N=31) PCS - AB FREE (N=21) PCS - TOTAL (N=31) Figure 3. Treatment effect of synbiotics on serum uremic toxins in all completing patients (n=31) and patients who were antibiotic free (n=21). a Treatment effect (95% confidence interval) derived from regression modeling accounting for period effect. *P=0.03; **P= Rossi et al, cjasn, 11: ;

44 REMOVAL OF INDOXYLSULFATE BY AST-120 PROTECTS GLOMERULAR FILTRATION RATE Akizawa T. et al, AJKD, 54: ;

45 egfr, relative to baseline REMOVAL OF INDOXYLSULFATE BY AST-120 PROTECTS GLOMERULAR FILTRATION RATE AST-120 Control Time (weeks) P<0.001 Akizawa T. et al, AJKD, 54: ;

46 AST-120 HAS NO PROTECTIVE EFFECT ON KIDNEY FUNCTION Schulman et al, JASN, 26: ;

47 AST-120 HAS NO PROTECTIVE EFFECT ON KIDNEY FUNCTION Schulman et al, doi: /ASN

48 AST-120 DOES NOT IMPACT ON PROGRESSION OF CKD Cha et al, cjasn, 2016, doi: /CJN

49 AST-120 DOES NOT IMPACT ON PROGRESSION OF CKD Progression (primary endpoint): - Screa x 2 - egfr / 2 - ESRD Figure 2. Occurrence of composite primary outcomes in each treatment arm. Log-rank P=0.45. Cha et al, cjasn, 2016, doi: /CJN

50 NOT DISCUSSED Uric acid Urea Advanced glycation end products Guanidines Other protein bound solutes (apart from indoxyl sulfate: e.g. p- cresyl sulfate, p-oh-hippuric acid, phenylacetic acid) Phenylacetylglutamine 50 50

51 NOT DISCUSSED Uric acid Urea Advanced glycation end products Guanidines Other protein bound solutes (apart from indoxyl sulfate and p- cresyl sulfate: p-oh-hippuric acid, phenylacetic acid) Phenylacetylglutamine 51 51

52 CONCLUSIONS The intestine plays a crucial role in the generation of uremic toxins 52 52

53 CONCLUSIONS The intestine plays a crucial role in the generation of uremic toxins This effect is further enhanced by: 53 53

54 CONCLUSIONS The intestine plays a crucial role in the generation of uremic toxins This effect is further enhanced by: Intestinal overgrowth of bacteria 54 54

55 CONCLUSIONS The intestine plays a crucial role in the generation of uremic toxins This effect is further enhanced by: Intestinal overgrowth of bacteria Disturbances of the intestinal epithelial barrier 55 55

56 CONCLUSIONS The intestine plays a crucial role in the generation of uremic toxins This effect is further enhanced by: Intestinal overgrowth of bacteria Disturbances of the intestinal epithelial barrier Translocation of intestinal microbiota 56 56

57 CONCLUSIONS The intestine plays a crucial role in the generation of uremic toxins This effect is further enhanced by: Intestinal overgrowth of bacteria Disturbances of the intestinal epithelial barrier Translocation of intestinal microbiota The results of therapeutic interventions to modify uremic toxin uptake via the intestine up to now have been deceiving but quality of most studies may be a matter of debate 57 57

58 Back-ups

59 MULTIFACTORIAL ANALYSIS: SOLUTE CONCENTRATION VS. VARIOUS FACTORS Eloot et al, Plos One, 8: e76838;

60 MULTIFACTORIAL ANALYSIS: SOLUTE CONCENTRATION VS. VARIOUS FACTORS Solute Covariates / R² full model Urea Normalized protein catabolic rate / Crea Normalized protein catabolic rate / Asymmetric dimethylarginine Symmetric dimethylarginine Uric acid Normalized protein catabolic rate / beta-2-microglobulin Residual renal function/ Hippuric acid Residual renal function / Normalized protein catabolic rate / Indoxyl sulfate Residual renal function / Indole acetic acid p-cresylsulfate Normalized protein catabolic rate / p-cresylglucuronide Residual renal function / Normalized protein catabolic rate / carboxy-4-methyl-5-propyl-2- furanpropionic acid age / Free hippuric acid Residual renal function / Free indoxyl sulfate Residual renal function / Free indole acetic acid Residual renal function / Free p-cresylsulfate Normalized protein catabolic rate / Residual renal function / Free p-cresylglucuronide Residual renal function / Normalized protein catabolic rate / Included: Age, gender, npcr, Kt/V, RRF, diabetes, body weight, vintage Eloot et al, Plos One, 8: e76838;

61 MULTIFACTORIAL ANALYSIS: SOLUTE CONCENTRATION VS. VARIOUS FACTORS Solute Covariates / R² full model Urea Normalized protein catabolic rate / Crea Normalized protein catabolic rate / Asymmetric dimethylarginine Symmetric dimethylarginine Uric acid Normalized protein catabolic rate / beta-2-microglobulin Residual renal function/ Hippuric acid Residual renal function / Normalized protein catabolic rate / Indoxyl sulfate Residual renal function / Indole acetic acid p-cresylsulfate Normalized protein catabolic rate / p-cresylglucuronide Residual renal function / Normalized protein catabolic rate / carboxy-4-methyl-5-propyl- 2-furanpropionic acid age / Free hippuric acid Residual renal function / Free indoxyl sulfate Residual renal function / Free indole acetic acid Residual renal function / Free p-cresylsulfate Normalized protein catabolic rate / Residual renal function / Free p-cresylglucuronide Residual renal function / Normalized protein catabolic rate / Included: Age, gender, npcr, Kt/V, RRF, diabetes, body weight, vintage Eloot et al, Plos One, 8: e76838;

62 DIET: UNCOOKED VEGAN DECREASES PROTEIN BOUND SOLUTES Ling et al, J Nutr, 122: ;

63 Serum concentration Serum concentration DIET: UNCOOKED VEGAN DECREASES PROTEIN BOUND SOLUTES Test Test Ling et al, J Nutr, 122: ;

64 P-CRESYLSULFATE INDUCES INSULIN RESISTANCE Koppe et al, JASN, 24: 88-99;

65 P-CRESYLSULFATE INDUCES INSULIN RESISTANCE Koppe et al, JASN, 24: 88-99;

66 PREBIOTIC AXOS REDUCES P-CRESYLSULFATE AND CORRECTS UREMIC INSULIN RESISTANCE IN MICE Koppe et al, JASN, 24: 88-99;

67 COMMON PATHWAYS IN ENDOTHELIUM Vanholder et al, JASN, 25: ;

68 PLASMA PROTEIN BOUND SOLUTES ARE DECREASED IN GERMFREE MICE Fig. 3. Sulfate profiling based on constant neutral loss scanning of 80 m/z in ESI mode for conv (Upper) and GF (Lower) pooled plasma samples. The m/z values for several species are listed above their respective peak. Identified sulfates include: phenyl sulfate (a), indoxyl sulfate (b), p-cresol sulfate (c), equol sulfate (d), and methyl equol sulfate (e). Wikoff et al, PNAS, 106: ;

69 DECREASE UREMIC TOXINS WITH SYNBIOTICS: RCT N=31 N=21 N=31 N=21 Figure 3. Treatment effect of synbiotics on serum uremic toxins in all completing patients (n=31) and patients who were antibiotic free (n=21). a Treatment effect (95% confidence interval) derived from regression modeling accounting for period effect. *P=0.03; **P= Rossi et al, cjasn, 11: ;

Impact de la convection

Impact de la convection Dysfonction Endothéliale, et toxines urémiques des patients dialysés Impact de la convection Ziad A. Massy Ambroise Paré Hospital, University Hospitals Paris Ile de France West, UVSQ, Boulogne Billancourt

More information

HEMODIAFILTRATION. R Vanholder University Hospital, Gent, Belgium Universitair Ziekenhuis Gent

HEMODIAFILTRATION. R Vanholder University Hospital, Gent, Belgium Universitair Ziekenhuis Gent HEMODIAFILTRATION R Vanholder University Hospital, Gent, Belgium UREMIC SOLUTES LISTED Vanholder et al, KI, 63:1934-1943; 2003 2 2 UREMIC SOLUTES LISTED Vanholder et al, KI, 63:1934-1943; 2003 3 3 UREMIC

More information

The intestine and the kidneys: a bad marriage can be hazardous

The intestine and the kidneys: a bad marriage can be hazardous Clin Kidney J (2015) 8: 168 179 doi: 10.1093/ckj/sfv004 Advance Access publication 10 February 2015 CKJ Review The intestine and the kidneys: a bad marriage can be hazardous Raymond Vanholder and Griet

More information

Effective Treatment Strategies to Delay the Progression of Renal Disease in CKD

Effective Treatment Strategies to Delay the Progression of Renal Disease in CKD Effective Treatment Strategies to Delay the Progression of Renal Disease in CKD Csaba P Kovesdy, MD FASN Memphis VA Medical Center, Memphis TN University of Tennessee, Memphis TN Vitamin D Metabolic acidosis

More information

Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease

Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease Poesen et al. BMC Nephrology 2014, 15:87 RESEARCH ARTICLE Open Access Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease Ruben Poesen 1, Liesbeth Viaene

More information

Novel technologies for blood purification Prof. Dr. Dimitrios Stamatialis

Novel technologies for blood purification Prof. Dr. Dimitrios Stamatialis Novel technologies for blood purification Prof. Dr. Dimitrios Stamatialis Biomaterials Science and Technology, MIRA institute, University of Twente 1 BST group MIRA: Technology for regeneration 5 My

More information

BONE AND MINERAL METABOLISM in the PD PATIENT

BONE AND MINERAL METABOLISM in the PD PATIENT BONE AND MINERAL METABOLISM in the PD PATIENT John Burkart, MD Professor of Medicine/Nephrology Wake Forest University Baptist Medical Center Chief Medical Officer Health Systems Management Maria V. DeVita,

More information

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics

More information

Personalising treatment of diabetic complications with a focus on A potential role for the gut microbiota in diabetic kidney complications

Personalising treatment of diabetic complications with a focus on A potential role for the gut microbiota in diabetic kidney complications Personalising treatment of diabetic complications with a focus on A potential role for the gut microbiota in diabetic kidney complications Peter Rossing MD DMSc University of Copenhagen Steno Diabetes

More information

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp

More information

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale Maurizio Gallieni Università degli Studi di Milano G Ital Nefrol 2018 - ISSN 1724-5990 Nutrients 2017, 9, 328 Vitamin D deficiency (

More information

What is the evidence that dietary components can act on the microbiome and influence health?

What is the evidence that dietary components can act on the microbiome and influence health? What is the evidence that dietary components can act on the microbiome and influence health? Kristin Verbeke Translational Research in Gastrointestinal Disorders KU Leuven, Leuven, Belgium Diet? health

More information

Dr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania

Dr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania Dr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania Nutritional management of CKD: Key-role of ketoanalogues with low protein diets

More information

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain Michael T. Bailey, Ph.D. Center for Microbial Pathogenesis The Research Institute, Nationwide Children s Hospital Department

More information

PART ONE. Peritoneal Kinetics and Anatomy

PART ONE. Peritoneal Kinetics and Anatomy PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.

More information

The Gut as a Source of Inflammation in Chronic Kidney Disease

The Gut as a Source of Inflammation in Chronic Kidney Disease Clinical Practice: Review Received: January 12, 2015 Accepted after revision: March 30, 2015 Published online: May 9, 2015 The Gut as a Source of Inflammation in Chronic Kidney Disease Wei Ling Lau Kamyar

More information

HDx THERAPY. Enabled by. Making possible personal.

HDx THERAPY. Enabled by. Making possible personal. HDx THERAPY Enabled by Making possible personal. THE NEXT HORIZON IN DIALYSIS IS CLOSER THAN YOU THINK PHOSPHATE UREA HDx BY THERANOVA EXPANDS YOUR RENAL POSSIBILITIES The new HDx therapy (expanded HD)

More information

Prognosis in CKD Can we do anything about it? Rodney D Gilbert

Prognosis in CKD Can we do anything about it? Rodney D Gilbert Prognosis in CKD Can we do anything about it? Rodney D Gilbert A diagnosis of end stage renal failure implies what degree of loss of life expectancy? A. 10% B. 20% C. 30% D. 40% E. 50% F. 60% 38% 22% 16%

More information

ENDPOINTS FOR AKI STUDIES

ENDPOINTS FOR AKI STUDIES ENDPOINTS FOR AKI STUDIES Raymond Vanholder, University Hospital, Ghent, Belgium SUMMARY! AKI as an endpoint! Endpoints for studies in AKI 2 AKI AS AN ENDPOINT BEFORE RIFLE THE LIST OF DEFINITIONS WAS

More information

in CKD Patients Associate Professorr of Medicine Iran University of Medical Sciences

in CKD Patients Associate Professorr of Medicine Iran University of Medical Sciences Management of Nutrition in CKD Patients Shokoufeh Sa avaj MD Associate Professorr of Medicine Iran University of Medical Sciences Introduction Dietary factors may have an effect on the progression of kidney

More information

Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components?

Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components? Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components? 3 rd International Conference of European Renal Nutrition Working Group of ERA-EDTA

More information

Uremic Cardiomyopathy with a focus on the role of α-klotho and FGF23

Uremic Cardiomyopathy with a focus on the role of α-klotho and FGF23 Uremic Cardiomyopathy with a focus on the role of α-klotho and FGF23 Marc G Vervloet, MD, PhD, FERA VU university medical center Amsterdam, The Netherlands Disclosures Scientific support AbbVie, Amgen,

More information

Role of the Gut Microbiota in Autoimmunity

Role of the Gut Microbiota in Autoimmunity Role of the Gut Microbiota in Autoimmunity Pavan Bhargava, MD - Neuroimmunology Fellow Division of Neuroimmunology and Neurological Infections Johns Hopkins University, Baltimore, MD. May, 2015 None Disclosures

More information

17 th Annual Meeting of JSHDF, Sept 3-4, 2011

17 th Annual Meeting of JSHDF, Sept 3-4, 2011 17 th Annual Meeting of JSHDF, Sept 3-4, 2011 Sug Kyun Shin 1, JY Moon 2, SW Han 3, DH Yang 4, SH Lee 2, HC Park 5, JK Kim 6 and YI Jo 7 1 Nephrology, NHIC Ilsan Hospital, 2 Kyunghee University Hospital

More information

Dialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012

Dialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012 Dialysis Dose Prescription and Delivery William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012 Dose in RRT: Key concepts Dose definition Quantifying

More information

Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center

Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease T. Alp Ikizler, MD Vanderbilt University Medical Center Nutrition and Chronic Kidney Disease What is the disease itself and

More information

Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease

Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease bs_bs_banner Therapeutic Apheresis and Dialysis 2015; 19(5):436 440 doi: 10.1111/1744-9987.12307 Review Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease

More information

Microbiome and Asthma

Microbiome and Asthma 제 12 차천식연구회 COPD 연구회공동심포지엄 Microbiome and Asthma 한양대학교병원호흡기알레르기내과 김상헌 Disclosure 내용 1 Lung Microbiome 2 Lung Microbiome and Asthma 3 Gut Microbiome and Asthma Microbiome and Microbiota human microbiome

More information

PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond

PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond PERITONEAL DIALYSIS ADEQUACY: The KDOQI Guidelines and Beyond John Burkart, M.D. Wake Forest University Baptist Medical Center CMO Health Systems Management 8/2014 John M. Burkart, MD Educational Grants

More information

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs

More information

Management of anemia in CKD. Masaomi Nangaku Division of Nephrology and Endocrinology the University of Tokyo Graduate School of Medicine, Japan

Management of anemia in CKD. Masaomi Nangaku Division of Nephrology and Endocrinology the University of Tokyo Graduate School of Medicine, Japan Management of anemia in CKD Masaomi Nangaku Division of Nephrology and Endocrinology the University of Tokyo Graduate School of Medicine, Japan Shiga toxin Kiyoshi Shiga 1871-1957 Shiga toxin binds to

More information

Contribution of Residual Function to Removal of Protein-Bound Solutes in Hemodialysis

Contribution of Residual Function to Removal of Protein-Bound Solutes in Hemodialysis Article Contribution of Residual Function to Removal of Protein-Bound Solutes in Hemodialysis Ilian O. Marquez,* Shouieb Tambra,* Frank Y. Luo,* You Li,* Natalie S. Plummer,* Thomas H. Hostetter, and Timothy

More information

Protein-bound uremic retention solutes are implicated in

Protein-bound uremic retention solutes are implicated in p-cresyl Sulfate and Indoxyl Sulfate in Hemodialysis Patients Björn K. I. Meijers,* Henriette De Loor,* Bert Bammens,* Kristin Verbeke, Yves Vanrenterghem,* and Pieter Evenepoel* *Department of Medicine,

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

Microbiome, allergy and inflammatory diseases

Microbiome, allergy and inflammatory diseases Microbiome, allergy and inflammatory diseases 1. NCDs & inflammation 2. Microbiome &GI inflammatory pathologies 3. Microbiome & autoimmunity 4. Microbiome & neurophaties 5. Microbiome & NAFLD 6. Microbiome

More information

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have

More information

HOW THE MICROBIOME AFFECTS OUR HEALTH

HOW THE MICROBIOME AFFECTS OUR HEALTH HOW THE MICROBIOME AFFECTS OUR HEALTH THE INTESTINAL BARRIER AND INTESTINAL PERMEABILITY Intestinal Barrier: a functional body Defense from translocation of dietary antigens, bacteria or bacterial endotoxins

More information

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD

More information

Towards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics"

Towards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics Towards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics" Kieran Tuohy for working group on Microbial Metabolism and Fermentation SUPPORTED BY THE ILSI EUROPE PREBIOTICS

More information

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different

More information

PREBIOTICS, THE INTESTINAL MICROBIOME AND BONE HEALTH

PREBIOTICS, THE INTESTINAL MICROBIOME AND BONE HEALTH PREBIOTICS, THE INTESTINAL MICROBIOME AND BONE HEALTH Corrie Whisner, PhD School of Nutrition and Health Promotion Arizona State University June 7, 2017 OVERVIEW 1. Osteoporosis 1. Prevalence 2. Prevention

More information

A Plant-Based Diet Prevents and Treats Chronic Kidney Disease

A Plant-Based Diet Prevents and Treats Chronic Kidney Disease 1 A Plant-Based Diet Prevents and Treats Chronic Kidney Disease Authors: Stewart Rose and Amanda Strombom Plant-Based Diets in Medicine Abstract Interest in the dietary treatment of chronic kidney disease

More information

Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report

Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report Qiurong Li Institute of General Surgery, Jinling Hospital Nanjing Univeristy Gut Microbiota 100 trillion cells 10-fold of

More information

Microbiome and liver diseases

Microbiome and liver diseases Klinik und Poliklinik für Innere Medizin I Microbiome and liver diseases Bernd Schnabl, M.D. Department of Medicine I have no financial relationship relevant to my presentation AND my presentation does

More information

Incremental Hemodialysis

Incremental Hemodialysis The 25 th Budapest Nephrology School, 2018 Incremental Hemodialysis a story about Hemodialysis and the Residual Kidney Function - a fairy tale? Csaba Ambrus Szent Imre Teaching Hospital, Div. of Nephrology-Hypertension

More information

Uremic solutes from colon microbes

Uremic solutes from colon microbes http://www.kidney-international.org & 2012 International Society of ephrology mini review Uremic solutes from colon microbes Timothy W. Meyer 1 and Thomas. ostetter 2 1 Department of Medicine, VA Palo

More information

Yoshie Kanazawa 1,2, Shunsuke Morita 3, Hirofumi Sonoki 3 and Toshiyuki Nakao 1,4*

Yoshie Kanazawa 1,2, Shunsuke Morita 3, Hirofumi Sonoki 3 and Toshiyuki Nakao 1,4* Kanazawa et al. Renal Replacement Therapy (2016) 2:18 DOI 10.1186/s41100-016-0031-5 RESEARCH Open Access Effects of a novel nutritional formula specially developed for chronic kidney disease patients on

More information

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this

More information

The New Cardiorenal Syndrome

The New Cardiorenal Syndrome The New Cardiorenal Syndrome Peter Sawaya, MD, FACP, FASN Professor of Medicine Fellowship Program Director University of Kentucky The Old Cardiorenal Syndrome Heart Perfusion Na Retention Kidney What

More information

Introduction to Clinical Diagnosis Nephrology

Introduction to Clinical Diagnosis Nephrology Introduction to Clinical Diagnosis Nephrology I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University of Florida College

More information

Important aspects of acid-base disorders

Important aspects of acid-base disorders Important aspects of acid-base disorders I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Division of Nephrology, Hypertension and Transplantation University of Florida College

More information

Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy

Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy Giuliana Magri, Ph.D Optimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations PRBB Auditorium, Barcelona October

More information

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) Thomas A. Golper MD, FACP, FASN Vanderbilt University Medical Center

More information

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications 1) Definition of CKD 2) Why should we screen

More information

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures GI MICROBIOME & HEALTH: A REVIEW Nancy C. Kois, MD, FCAP Contemporary Pathology Services DISCLOSURES There are no disclosures OBJECTIVES Definitions: GI microbiota, GI microbiome, probiotic, prebiotic

More information

Welcome to the UK Primary Hyperoxaluria family support day

Welcome to the UK Primary Hyperoxaluria family support day Welcome to the UK Primary Hyperoxaluria family support day Understanding Primary Hyperoxaluria (PH) / Oxalosis together Dr Sally-Anne Hulton Kim Hollander % PH Patients PH is diagnosed at any age 50 45

More information

GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH?

GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH? GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH? Corrie Whisner, PhD School of Nutrition and Health Promotion Arizona State University Center for Research on Ingredient Safety Annual Meeting

More information

IJBCP International Journal of Basic & Clinical Pharmacology

IJBCP International Journal of Basic & Clinical Pharmacology Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20171028 Original Research Article A prospective

More information

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,

More information

Pediatric Nutrition and Kidney Disease

Pediatric Nutrition and Kidney Disease Pediatric Nutrition and Kidney Disease Loai Eid, MD, MSHS, FAAP Consultant Pediatric Nephrologist Pediatric Nephrology & Hypertension Division Chief Dubai Hospital - DHA 26 th October, 2017 Objectives

More information

Dysbiosis & Inflammation

Dysbiosis & Inflammation MASTERING THE MICROBIOME: Dysbiosis & Inflammation 2017 Tom Fabian, PhD It is reasonable to propose that the composition of the microbiome and its activities are involved in most, if not all, of the biological

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature12198 1. Supplementary results 1.1. Associations between gut microbiota, glucose control and medication Women with T2D who used metformin had increased levels of Enterobacteriaceae (i.e.

More information

The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells.

The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells. The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells. The number of microorganisms residing in our intestines is 10 times the number of our somatic

More information

Novel Biomarkers in Critically Ill Patients and the Emergency Room

Novel Biomarkers in Critically Ill Patients and the Emergency Room Novel Biomarkers in Critically Ill Patients and the Emergency Room Jay L. Koyner MD Section of Nephrology University of Chicago Research Funding: NIDDK, Abbvie, Astute, Argutus Outline Background / Pitfalls

More information

Original Article. Correspondence and offprint requests to: Tom Cornelis; * Equal senior authorship contribution.

Original Article. Correspondence and offprint requests to: Tom Cornelis;   * Equal senior authorship contribution. Nephrol Dial Transplant (2015) 30: 1395 1402 doi: 10.1093/ndt/gfv038 Advance Access publication 9 April 2015 Original Article Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end

More information

IN THE NAME OF GOD Uremic toxins I. Small (< 500 D); water soluble Surrogate marker urea or sodium (ionic dialysance) Rapidly produced in intracellular fluid compartment Large variability in intra-patient

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Level of renal function at which to initiate dialysis GUIDELINES Level of renal function at which to initiate dialysis Date written: September 2004 Final submission: February 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR

More information

Achieving Equilibrium in ESRD Patients

Achieving Equilibrium in ESRD Patients Achieving Equilibrium in ESRD Patients -Marc Richards MD -South Florida Kidney Disease and HTN Specialists -Chief of Medicine, BRRH -BRRH Grand Rounds: April 18 th, 2017 Outline Dialysis prescription Adequacy

More information

Analysis of the effect of probiotics on shaping human gut microbiota

Analysis of the effect of probiotics on shaping human gut microbiota Analysis of the effect of probiotics on shaping human gut microbiota Masahira HATTORI Center for Omics and Bioinformatics, The University of Tokyo http://www.cb.k.u-tokyo.ac.jp/hattorilab

More information

INSIDER S GUIDE Organic Acids: Dysbiosis By Ron Grisanti, D.C. & Dicken Weatherby, N.D.

INSIDER S GUIDE Organic Acids: Dysbiosis By Ron Grisanti, D.C. & Dicken Weatherby, N.D. Functional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE Organic Acids: Dysbiosis By Ron Grisanti, D.C. & Dicken Weatherby, N.D. http://www.functionalmedicineuniversity.com

More information

The role of gut microbiome in IBS

The role of gut microbiome in IBS The role of gut microbiome in IBS Chung Owyang, MD H. Marvin Pollard Professor of Internal Medicine Professor of Molecular and Integrative Physiology Chief, Division of Gastroenterology Director, Pollard

More information

Gut Reaction. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD

Gut Reaction. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD Gut Reaction Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD Ley, R. et al (2005) PNAS vol. 102 no. 31 Bacterial diversity in the distal gut (ceca) of C57BL6 mice. (A) Phylogenetic tree of

More information

Summary of Product Characteristics

Summary of Product Characteristics Brand Name: OXALO [Pre Probiotic] Capsules Therapeutic Category: Prevention of Stone Formation Urinary tract stone disease has been a part of the human condition for millennia; in fact, bladder and kidney

More information

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this

More information

Module Outline. 1. Microbiome overview: getting a sense of the microbiome, research, what we know

Module Outline. 1. Microbiome overview: getting a sense of the microbiome, research, what we know Module Outline 1. Microbiome overview: getting a sense of the microbiome, research, what we know 2. Bacteria: features, functions, communities & taxonomy 3. Other microbes: archaea, fungi, viruses, parasites

More information

Benakis et al. Supplementary Figure 1

Benakis et al. Supplementary Figure 1 Benakis et al. Supplementary Figure a flora Naive C7BL/ d AC weeks d S rrna sequencing Antibiotic in drinking water Stool pellet collection riginal seeder flora flora Naive C7BL/ d AC weeks d S rrna sequencing

More information

AXITAB-CV TAB. COMPOSITION :

AXITAB-CV TAB. COMPOSITION : AXITAB-CV TAB. COMPOSITION : Each film coated tablet contains: Cefuroxime Axetil I.P. Eq. to Anhydrous 500mg. Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 125mg DESCRIPTION : Cefuroxime Axetil

More information

Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy?

Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy? Clinical Practice: Second Opinion Received: July 29, 2016 Accepted after revision: November 22, 2016 Published online: December 14, 2016 Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy?

More information

Diet-microbiome-health interactions in older people

Diet-microbiome-health interactions in older people Diet-microbiome-health interactions in older people Paul W. O Toole Prof. Microbial Genomics School of Microbiology, Univ. College Cork, Ireland APC Microbiome Institute, Univ. College Cork, Ireland http://apc.ucc.ie

More information

Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute

Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute Jennifer T. Smilowitz, PhD Associate Director, Human Studies Research jensm@ucdavis.edu

More information

EFFECTS OF ANTIBIOTIC PROPHYLAXIS ON THE PERFORMANCE AND GUT MICROBIOTA OF GROWING BROILER CHICKS

EFFECTS OF ANTIBIOTIC PROPHYLAXIS ON THE PERFORMANCE AND GUT MICROBIOTA OF GROWING BROILER CHICKS EFFECTS OF ANTIBIOTIC PROPHYLAXIS ON THE PERFORMANCE AND GUT MICROBIOTA OF GROWING BROILER CHICKS Alexandra Tonks Supervisors: Dr Caroline Rymer, Prof Martin Woodward School of Agriculture, University

More information

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George Uric acid and CKD Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George Hospital @Badves Case Mr J, 52 Male, referred in June 2015 DM type 2 (4 years), HTN, diabetic retinopathy, diabetic

More information

Lithium toxicity. Dr Aude Servais Service de Néphrologie adulte Hôpital Necker, Paris

Lithium toxicity. Dr Aude Servais Service de Néphrologie adulte Hôpital Necker, Paris Lithium toxicity Dr Aude Servais Service de Néphrologie adulte Hôpital Necker, Paris Lithium Use of lithium salts as salt substitutes but recall from the marketplace in 1949 Efficient in the treatment

More information

AKI: definitions, detection & pitfalls. Jon Murray

AKI: definitions, detection & pitfalls. Jon Murray AKI: definitions, detection & pitfalls Jon Murray Previous conventional definition Acute renal failure (ARF) An abrupt and sustained decline in renal excretory function due to a reduction in glomerular

More information

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal

More information

GFR and Drug Dosage Adaptation: Are We still in the Mist?

GFR and Drug Dosage Adaptation: Are We still in the Mist? GFR and Drug Dosage Adaptation: Are We still in the Mist? Pierre Delanaye, MD, PhD Nephrology, Dialysis, Transplantation CHU Sart Tilman University of Liège BELGIUM I have no conflict of interest to declare

More information

THE NKF-KDOQI (2002) CKD DEFINITION AND CLASSIFICATION SYSTEM: Limitations and Problems

THE NKF-KDOQI (2002) CKD DEFINITION AND CLASSIFICATION SYSTEM: Limitations and Problems THE NKF-KDOQI (2002) CKD DEFINITION AND CLASSIFICATION SYSTEM: Limitations and Problems Richard J. Glassock, MD, MACP David Geffen School of Medicine at UCLA KDIGO Controversies Conference London, UK October

More information

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI Gut Microbiota and IBD Vahedi. H M.D Associate Professor of Medicine DDRI 1393.3.1 2 GUT MICROBIOTA 100 Trillion Microbes - 10 times more than cells in our body Collective weight of about 1kg in human

More information

International Journal of Innovative Pharmaceutical Sciences and Research

International Journal of Innovative Pharmaceutical Sciences and Research International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com THE EFFECT OF N-ACETYL CYSTEINE THERAPY IN THE MANAGEMENT OF INFECTIONS ON PATIENTS WITH CHRONIC KIDNEY DISEASE 1

More information

The Gut Microbiome: 101 Justin Carlson University of Minnesota

The Gut Microbiome: 101 Justin Carlson University of Minnesota The Gut Microbiome: 101 Justin Carlson University of Minnesota Where are we now? 360 B.C. 2003 Human Gut Microbes Associated With Obesity Ley et al., Nature. 2006. Consumer Driven Science For Better of

More information

Mark Manary MD. International Symposium on Understanding Moderate Malnutrition in Children for Effective Interventions

Mark Manary MD. International Symposium on Understanding Moderate Malnutrition in Children for Effective Interventions Possible role of the microbiome in the development of acute malnutrition and implications for food-based strategies to prevent and treat acute malnutrition International Symposium on Understanding Moderate

More information

HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS 1.0 PRACTICE CONSIDERATIONS 2.0 CURRENT LITERATURE REVIEW

HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS 1.0 PRACTICE CONSIDERATIONS 2.0 CURRENT LITERATURE REVIEW HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS This document was prepared at the request of the BC Hemodialysis Committee to provide a brief overview of the literature and to identify

More information

SLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota

SLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota SLOWING PROGRESSION OF KIDNEY DISEASE Mark Rosenberg MD University of Minnesota OUTLINE 1. Epidemiology of progression 2. Therapy to slow progression a. Blood Pressure control b. Renin-angiotensin-aldosterone

More information

Non-protein nitrogenous substances (NPN)

Non-protein nitrogenous substances (NPN) Non-protein nitrogenous substances (NPN) A simple, inexpensive screening test a routine urinalysis is often the first test conducted if kidney problems are suspected. A small, randomly collected urine

More information

HIHIM 409 7/26/2009. Kidney and Nephron. Fermamdo Vega, M.D. 1

HIHIM 409 7/26/2009. Kidney and Nephron. Fermamdo Vega, M.D. 1 Function of the Kidneys Nephrology Fernando Vega, M.D. Seattle Healing Arts Center Remove Wastes Regulate Blood Pressure Regulate Blood Volume Regulates Electrolytes Converts Vitamin D to active form Produces

More information

Actisaf Advanced management in horse nutrition for better performance. phileo-lesaffre.com LESAFFRE ANIMAL CARE

Actisaf Advanced management in horse nutrition for better performance. phileo-lesaffre.com LESAFFRE ANIMAL CARE Advanced management in horse nutrition for better performance phileo-lesaffre.com LESAFFRE ANIMAL CARE improves feed utilization In trials carried out in various locations, has repeatedly and consistently

More information

Review Article Pre-, Pro-, and Synbiotics: Do They Have a Role in Reducing Uremic Toxins? A Systematic Review and Meta-Analysis

Review Article Pre-, Pro-, and Synbiotics: Do They Have a Role in Reducing Uremic Toxins? A Systematic Review and Meta-Analysis Hindawi Publishing Corporation International Journal of Nephrology Volume 2012, Article ID 673631, 20 pages doi:10.1155/2012/673631 Review Article Pre-, Pro-, and Synbiotics: Do They Have a Role in Reducing

More information

Supplementary Figures and Tables

Supplementary Figures and Tables Supplementary Figures and Tables Supplementary Figure 1. Intestinal epithelial MyD88 deletion decreases fat mass under HFD. (a) Final fat mass expressed as a percentage of final body weight (n=25). (b)

More information

general meeting 1 20 October 2016

general meeting 1 20 October 2016 general meeting 1 20 October 2016 introductions today s topics the human microbiome about the study the human microbiome the human microbiome human microbiota: the microorganisms that live within and on

More information